Phase I study of erlotinib and hydroxychloroquine in non-small cell lung cancer

被引：0
|
作者：
Sequist, Lecia, V [1 ]
Sharma, Sreenath, V [1 ]
Supko, Jeffrey G. [1 ]
Neal, Joel W. [1 ]
Fidias, Panos [1 ]
Temel, Jennifer [1 ]
Heist, Suk Rebecca [1 ]
Shaw, Alice T. [1 ]
Engelman, Jeffrey A. [1 ]
Settleman, Jeffrey E. [1 ]
Lynch, Thomas J. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S712 / S713
页数：2
相关论文
共 50 条
  • [21] Phase 1b study of capecitabine and erlotinib in advanced non-small cell lung cancer
    Lu, S.
    Popat, S.
    Puglisi, M.
    Kaudeer, N.
    Gennatas, S.
    Hewish, M.
    Ayite, B.
    Bhosle, J.
    O'Brien, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S828 - S828
  • [22] Phase II study of chemoradiation therapy and erlotinib for stage Ill non-small cell lung cancer
    Komaki, Ritsuko U.
    Wistuba, Ignacio
    Tang, Xi Ming
    Meyn, Raymond E.
    Lee, J. Jack
    Wei, Xiong
    Allen, Pamela K.
    O'Reilly, Michael S.
    Welsh, James
    Hong, Wuan Ki
    CANCER RESEARCH, 2011, 71
  • [23] Experience with erlotinib in the treatment of non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 146 - 163
  • [24] Combination of quinacrine and erlotinib overcomes resistance to erlotinib in non-small cell lung cancer
    Dermavvan, Josephine Kam Tai
    Gurova, Katerina
    Pink, John
    Dowlati, Afshin
    De, Sarmishtha
    Naria, Goutham
    Sharma, Neelesh
    Stark, George
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [25] PHASE I STUDY OF PATRITUMAB (U3-1287) IN COMBINATION WITH ERLOTINIB IN JAPANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Murakami, H.
    Yamamoto, N.
    Kudo, K.
    Nishio, M.
    Kaneda, H.
    Nakagawa, K.
    Horinouchi, H.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [26] Phase I and Pharmacokinetic Study of Erlotinib Administered in Combination With Amrubicin in Patients With Previously Treated, Advanced Non-small Cell Lung Cancer
    Otani, Sakiko
    Hamada, Akinobu
    Sasaki, Jiichiro
    Wada, Mayuko
    Yamamoto, Michiko
    Ryuge, Shinichiro
    Takakura, Akira
    Fukui, Tomoya
    Yokoba, Masanori
    Mitsufuji, Hisashi
    Toyooka, Issei
    Maki, Sachiyo
    Kimura, Michiko
    Hayashi, Nobuatsu
    Ishihara, Mikiko
    Kasajima, Masashi
    Hiyoshi, Yasuhiro
    Katono, Ken
    Asakuma, Maiko
    Igawa, Satoshi
    Kubota, Masaru
    Katagiri, Masato
    Saito, Hideyuki
    Masuda, Noriyuki
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04): : 405 - 410
  • [27] PHASE I AND PHARMACOKINETIC STUDY OF ERLOTINIB ADMINISTERED IN COMBINATION WITH AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED NON-SMALL CELL LUNG CANCER
    Otani, Sakiko
    Hamada, Akinobu
    Sasaki, Jiichiro
    Yamamoto, Michiko
    Ryuge, Shinichiro
    Takakura, Akira
    Fukui, Tomoya
    Yokoba, Masanori
    Mitsufuji, Hisashi
    Toyooka, Issei
    Maki, Sachiyo
    Kubota, Masaru
    Katagiri, Masato
    Saito, Hideyuki
    Masuda, Noriyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1165 - S1165
  • [28] Phase I/II study of paclitaxel and radiotherapy in non-small cell lung cancer
    Marangolo, M
    Emiliani, E
    Rosti, G
    Giannini, M
    Vertogen, B
    Zumaglini, F
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 124 - 127
  • [29] Paclitaxel and carboplatin: A phase I study in advanced non-small cell lung cancer
    Paccagnella, A
    Favaretto, A
    Oniga, F
    Ossana, L
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 76 - 79
  • [30] Phase I study of rilotumumab (AMG 102), an HGF inhibitor, and erlotinib in patients with advanced non-small cell lung cancer (NSCLC).
    Phu Tran
    Gooding, William E.
    Villaruz, Liza Cosca
    Burns, Timothy Francis
    Socinski, Mark A.
    Tarhini, Ahmed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345